Drug Trial Radar · NCT03235024
Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Oct 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
122
Actual
Start
Jan 15, 2018
Primary completion
Feb 27, 2019
Study completion Mar 20, 2019
Sponsor
- Lead sponsor
- AOBiome LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Veristat, Inc.
- First posted
- Aug 1, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized Phase II trial, comparing the effect of twice daily B244 application for 28 days vs vehicle application on treatment of mild to moderate AD
Conditions
- Atopic Dermatitis Eczema
Interventions
B244Biological
B244 suspension
VehicleBiological
Vehicle suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0Time frame: Baseline to Day 42
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Central Research Associates
Birmingham, Alabama
Elite Clinical Studies
Phoenix, Arizona
Encino Research Center
Encino, California
Orange County Research Center
Tustin, California
Neostart Corporation d.b.a AGA Clinical Trials
Hialeah, Florida
Clinical Neuroscience Solution, Inc
Jacksonville, Florida
FXM Research Corp.
Miami, Florida
FXM Research Miramar
Miramar, Florida
Clinical Neuroscience Solution, Inc
Orlando, Florida
Clinical Research Trials of Florida, Inc.
Tampa, Florida
Columbus Regional Research Institute
Columbus, Georgia
DeNova Research dba Arano, LLC
Chicago, Illinois
Clarkston Skin Research
Clarkston, Michigan
MediSearch Clinical Trials
Saint Joseph, Missouri
LoveLace Scientific Resources
Albuquerque, New Mexico
Central Sooner Research
Norman, Oklahoma
Paddington Testing Co.
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.